13 January 2026 : Clinical Research
Comparative Outcomes of Tricuspid-Dedicated Versus Non-Dedicated Devices in Transcatheter Tricuspid Edge-to-Edge Repair
Adam Rdzanek
ABCDEF 1, Adam Piasecki ABCDEF 1, Mariusz Tomaniak ADE 1*, Ewa Pędzich ADE 1, Ewa Ostrowska BE 1, Paweł Pawłowicz BE 1, Agnieszka Kapłon-Cieślicka BE 1, Piotr Scisło ABE 1
DOI: 10.12659/MSM.950175
Med Sci Monit 2026; 32:e950175
Table 3 Procedural characteristics and technical, echocardiographic, and clinical outcomes.
| Parameter | OverallN=44 | Non-dedicated (MitraClip) N=22 | Dedicated (TriClip or PASCAL) N=22 | P value |
|---|---|---|---|---|
| Isolated T-TEER | 17 (38.6%) | 0 (0.0%) | 17 (77.3%) | |
| Single-procedure MT-TEER | 20 (45.5%) | 22 (100%) | 0 (0.0%) | |
| Staged MT-TEER | 7 (15.9%) | 0 (0.0%) | 5 (22.7%) | |
| Successful implantation | 39 (88.6%) | 17 (77.3%) | 22 (100%) | |
| TR moderate or less | 34 (77.3%) | 16 (72.7%) | 18 (81.8%) | 0.47 |
| TR moderate or less and reduction of at least 2 grades | 22 (50.0%) | 7 (31.8%) | 15 (68.2%) | |
| Any complication | 6 (13.6%) | 5 (22.7%) | 1 (4.5%) | 0.16 |
| SLDA | 2 (4.5%) | 1 (4.5%) | 1 (4.5%) | 0.99 |
| Other complications | 2 (4.5%) | 2 (9.1%) | 0 (0.0%) | 0.49 |
| Hemoptysis | 1 (2.3%) | 1 (4.5%) | 0 (0.0%) | 0.99 |
| TIA | 1 (2.3%) | 1 (4.5%) | 0 (0.0%) | 0.99 |
| 6 months follow-up | 43 (97.7%) | 22 (100%) | 21 (95.5%) | 0.31 |
| Mortality 6 months | 2 (4.7%) | 2 (9.1%) | 0 (0.0%) | 0.23 |
| MT-TEER – mitral and tricuspid transcatheter edge-to-edge repair; T-TEER – tricuspid transcatheter edge-to-edge repair; MV mitral valve; SLDA – single-leaflet device attachment; TIA – transient ischemic attack; TR – tricuspid regurgitation; T-TEER – tricuspid transcatheter edge-to-edge repair; TV – tricuspid valve. | ||||